| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
SUPPLEMENT |
National Cancer Institute/National Institutes of Health, Bethesda, Maryland, USA
Correspondence: Gregory A. Curt, M.D., Clinical Director, National Cancer Institute/National Institutes of Health, Oncology Program, Building 10, Room 12N214, 9000 Rockville Pike, Bethesda, Maryland 20892, USA. Telephone: 301-496-4251; Fax: 301-496-9020; e-mail: curtg{at}pbmac.nci.nih.gov
Fatigue is a complex, multifactorial disorder with physical, mental, and psychological dimensions that has been associated with diminished quality of life (QOL) in patients with cancer. The prevalence and severity of fatigue, however, has only recently been studied systematically. Two national surveys commissioned by The Fatigue Coalition, a multidisciplinary group of medical practitioners, researchers, and patient advocates, whose mission is to study the importance of fatigue for patients with cancer and their caregivers, have assessed the prevalence, severity, and QOL consequences of fatigue in patients with cancer. The most recent survey, initiated in 1998, sought to confirm and extend observations on the prevalence and impact of fatigue in patients with cancer as part of an initiative to develop guidelines for the differential diagnosis and treatment of fatigue. The FATIGUE 2 study probed the emotional, social, physical, and economic impact of fatigue on patients with cancer and their caregivers. Patient perceptions of the professional response to cancer-related fatigue were also assessed. The key findings of these surveys are reviewed. 2000;5(suppl 2): 9-12
This article has been cited by other articles:
 |
|
 |
|
  A. Sood, D. L. Barton, B. A. Bauer, and C. L. Loprinzi A Critical Review of Complementary Therapies for Cancer-Related Fatigue Integr Cancer Ther, March 1, 2007; 6(1): 8 - 13. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Barrett-Lee, C. Bokemeyer, P. Gascon, J.W.R. Nortier, M. Schneider, D. Schrijvers, S. Van Belle, and for the Ecas Advisory Board and Participating Cent Management of Cancer-Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the European Cancer Anemia Survey Oncologist, October 1, 2005; 10(9): 743 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Hjermstad, S. D. Fossa, L. Oldervoll, H. Holte, A. B. Jacobsen, and J. H. Loge Fatigue in Long-Term Hodgkin's Disease Survivors: A Follow-Up Study J. Clin. Oncol., September 20, 2005; 23(27): 6587 - 6595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Reinhardt, A. Tulusan, R. Angermund, H. Lutz, and For The German Epoetin Alfa Study Group Increased Hemoglobin Levels and Improved Quality-of-Life Assessments During Epoetin Alfa Treatment in Anemic Cancer Patients: Results of a Prospective, Multicenter German Trial Oncologist, March 1, 2005; 10(3): 225 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hudis, S. Van Belle, J. Chang, and K. Muenstedt rHuEPO and Treatment Outcomes: the Clinical Experience Oncologist, November 1, 2004; 9(suppl_5): 55 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Flechtner and A. Bottomley Fatigue and Quality of Life: Lessons from the Real World Oncologist, February 1, 2003; 8(90001): 5 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Holzner, G. Kemmler, R. Greil, M. Kopp, A. Zeimet, M. Raderer, M. Hejna, S. Zochbauer, G. Krajnik, H. Huber, et al. The impact of hemoglobin levels on fatigue and quality of life in cancer patients Ann. Onc., June 1, 2002; 13(6): 965 - 973. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| THE ONCOLOGIST | STEM CELLS | CME | ALPHAMED PRESS JOURNALS |
